Director, Managed Markets and Patient Support Services Marketing at Dyno Therapeutics

Waltham, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Extensive market access experience, particularly in product launches in neuromuscular disease or similar therapeutic areas
Proven ability to build, recruit, and lead high-performing teams of market access experts
Strong strategic thinking and execution skills as a self-starter who is highly driven and collaborative
Expertise in developing and implementing payer engagement strategies, strategic account plans, pricing, and contracting
Experience negotiating contracts, analyzing financial and utilization data, and minimizing reimbursement barriers
Knowledge of commercial, government payers (e.g., Medicaid), healthcare policies, and regulations
Ability to cultivate senior stakeholder relationships with external partners (e.g., CEOs, CFOs, medical directors, state officials)
Cross-functional collaboration skills with teams like Marketing, Medical Affairs, Patient Services, HEOR, and Advocacy
Agility, bold thinking, and execution-focus to adapt to evolving healthcare landscape

Responsibilities

Design a fit-for-purpose market access organization to enable broad and timely access to Dyne therapies
Build, recruit, and nurture a high-performing team of market access experts
Develop and implement a comprehensive payer engagement strategy to support the launch and lifecycle management of Dyne’s product(s)
Develop and execute strategic account plans to identify opportunities for business growth and improved patient access to therapies or services
Eliminate or significantly reduce barriers to access and reimbursement for portfolio of products, inclusive of drug and procedural code coverage
Collaborate with internal and external stakeholders to leverage and implement reimbursement, managed care, payer, and healthcare policies that ensure attainment of business objectives
Design and drive Dyne’s development of payer account management/outreach as well as pricing and contracting (as needed) for optimal reimbursement and robust market penetration
Establish and strengthen successful business partnerships with external partners and stakeholders, including executive management, medical directors, key physicians, and secondary customers (pharmacists, nurses, etc.)
Oversee compliance, analyze financial and utilization data, and align with organizational goals across cross-functional teams

Skills

Market Access

Payer Negotiations

Contract Management

Account Management

Stakeholder Engagement

Reimbursement Strategy

Healthcare Compliance

Financial Analysis

Utilization Data Analysis

Strategic Planning

Payer Engagement

Commercial Payers

Government Payers

Medicaid

Launch Readiness

Commercialization

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters

2018Year Founded

$106MTotal Funding

SERIES_ACompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.

Manufacturing bottlenecks could hinder scaling of Dyno's operations.

Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.

Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.

Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.

Collaboration with NVIDIA enhances biological sequence design for gene therapies.

Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free